The molecular mechanisms and therapeutic potential of EZH2 in breast cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Breast cancer is a leading cause of mortality, with epigenetic alterations playing a key role in its development.
• Enhancer of zeste homolog 2 (EZH2) is an epigenetic regulator implicated in various cellular functions.
• EZH2 dysregulation, particularly overexpression, is observed in advanced breast cancer stages.

Purpose of the Study:

• To review the biological functions and novel mechanisms of EZH2.
• To elucidate the role of EZH2 in breast cancer initiation, progression, metastasis, and invasion.
• To highlight EZH2 as a potential therapeutic target for breast cancer treatment.

Main Methods:

• Literature review of existing studies on EZH2 and breast cancer.
• Analysis of EZH2's molecular mechanisms and action modes.
• Synthesis of evidence linking EZH2 to breast cancer pathophysiology.

Main Results:

• EZH2 exhibits diverse action modes influencing vital cellular functions.
• EZH2 overexpression or dysfunction significantly impacts breast cancer development and progression.
• EZH2 is involved in key processes including initiation, metastasis, and invasion.

Conclusions:

• EZH2 plays a critical role in the multifaceted aspects of breast cancer.
• Understanding EZH2's mechanisms provides insights into breast cancer pathogenesis.
• EZH2 represents a promising therapeutic target for novel breast cancer treatments.